ATPW
ANIP icon

Ashton Thomas Private Wealth’s ANI Pharmaceuticals ANIP Stock Holding History

Ashton Thomas Private Wealth’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
3,971
-1
-0% -$80 0.01% 949
2026
Q1 		$305K Buy
+3,972
New +$310K 0.01% 879

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ashton Thomas Private Wealth's ANIP Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its ANI Pharmaceuticals (ANIP) stake by 0.03% in Q2 2026, selling an estimated $80 and leaving 3,971 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #949.

Ashton Thomas Private Wealth first reported a position in ANIP in Q1 2026 and has held it in 2 quarters since. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Ashton Thomas Private Wealth held 3,971 shares of ANI Pharmaceuticals worth $329K as of Q2 2026.
  • Ashton Thomas Private Wealth sold 1 ANI Pharmaceuticals share in Q2 2026, an estimated $80.
  • ANI Pharmaceuticals made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #949 holding.
  • Ashton Thomas Private Wealth first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.